ArticleJournal of cancer education : the official journal of the American Association for Cancer Education2026
Reassurance as Cancer Education after a Benign Investigation.
Article in Journal of cancer education : the official journal of the American Association for Cancer Education, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cancer education is typically associated with diagnosis and treatment, yet patients undergoing cancer assessment who receive benign results also experience significant psychological and educational impact. This article reframes reassurance as an active clinical and educational process, emphasising its role in shaping patients' understanding of symptoms, risk, and future help-seeking. It proposes a structured approach to post-assessment communication, including explaining the rationale for investigation, defining the limits of reassurance, and supporting ongoing symptom awareness. The paper highlights the importance of continuity, equity, and tailored communication strategies, arguing that benign cancer assessments represent critical, under-recognised opportunities for meaningful patient education.
Indexed as
Identifiers
42101578What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.